PUBLIC COMPANY
saveNanoscope Therapeutics Inc
updated 3mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Preclinical1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- —A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection
- —Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
- —A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
- —Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study
- phase2Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
- —Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT
- phase2Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease
🐶 Hiring Signal
News
- ‘We’re making a lot of progress’: How Nobel-winning optogenetics is being harnessed by biotechsAs a notorious night owl, it was already very early in the morning of October 5 when Karl Deisseroth, M.D., Ph.D., finally laid down to get some shuteye. Not long after, the phone of the Stanford p…fiercebiotech · 1mo ago
- Trio of scientists who developed neuron light switches win Nobel Prize in Physiology or MedicineThe 2026 Nobel Prize in Physiology or Medicine has been awarded to three scientists who forged a new neuroscience technique that uses light to precisely flip chosen neurons on and off.fiercebiotech · 1mo ago
comments(0)
5-min edit window · permanent after that